69 / 100

Dr. Roberto Lugo | Clinical Research Awardย | Best Researcher Award.

Hospital Regional de Alta Especialidad de la Penรญnsula de Yucatรกn-IMSS Bienestar ,Mexico

Professional Profiles:

SCOPUS

GOOGLE SCHOLAR

๐Ÿ‘จโ€๐ŸŽ“ Bio Summary:

Dr. Roberto Lugo is a Health Researcher based in Merida, Mexico. ๐Ÿ‡ฒ๐Ÿ‡ฝ He is a researcher at the Hospital Regional de Alta Especialidad de la Peninsula de Yucatan and a member of the National System of Investigators. With over twenty years of experience, Dr. Lugo specializes in cancer research and chronic kidney disease. He has a strong background in designing and leading scientific projects, collaborating with national and international research networks, and managing molecular and cellular biology laboratories. His expertise also includes image analysis, statistical analysis of biological data, signal processing, mathematical modeling, and molecular techniques. Dr. Lugo holds a PhD in Biomedicine from the Universitat de Barcelona, a Master’s in Biomedical Engineering from the Institute for Bioengineering of Catalonia, Universitat de Barcelona, and a Bachelor’s in Biochemistry Engineering from the Instituto Tecnologico de Merida.

๐ŸŽ“ Education:

Dr. Lugo earned his PhD in Biomedicine from the Universitat de Barcelona, focusing on the study of the phenotypic heterogeneity of Tumor-Associated Fibroblasts in Lung Cancer. He completed his Master’s in Biomedical Engineering at the Institute for Bioengineering of Catalonia, where he worked on Ion-Selective Electrode development for pH detection. He obtained his Bachelor’s in Biochemistry Engineering from the Instituto Tecnologico de Merida, conducting research on the effects of temperature on the quality characteristics of dehydrated habanero chili peppers.

๐Ÿ” Research Focus:

Dr. Lugo’s research focuses on cancer, particularly the phenotypic heterogeneity of Tumor-Associated Fibroblasts in Lung Cancer. He also studies chronic kidney disease and its association with urinary stone composition, surgical resection impact on survival in gastric cancer patients, and the relationship between metabolic syndrome and hyperuricemia.

๐Ÿ† Honors & Awards:

Dr. Lugo has received several honors and awards for his contributions to the field of biomedical research.

Professional Experience: ๐Ÿ’ผ

Dr. Lugo has over twenty years of experience in biomedical research, with a focus on cancer and chronic kidney disease. He has led and supervised scientific projects, collaborated with research networks, managed laboratories, and presented findings at national and international conferences.

๐Ÿ“š Top Noted Publications :

Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts – This study, published in Carcinogenesis in 2015, explores the role of DNA methylation in non-small cell lung cancer-associated fibroblasts, highlighting its potential impact on cancer development and progression.

Matrix Stiffening and ฮฒ1 Integrin Drive Subtype-Specific Fibroblast Accumulation in Lung Cancer – Published in Molecular Cancer Research in 2015, this research investigates how matrix stiffening and ฮฒ1 integrin contribute to subtype-specific fibroblast accumulation in lung cancer, shedding light on mechanisms driving cancer progression.

Epithelial contribution to the profibrotic stiff microenvironment and myofibroblast population in lung fibrosis – This study, published in Molecular Biology of the Cell in 2017, examines the contribution of epithelial cells to the profibrotic stiff microenvironment and myofibroblast population in lung fibrosis, providing insights into the disease mechanism.

Miniaturizable ion-selective arrays based on highly stable polymer membranes for biomedical applications – Published in Sensors in 2014, this research focuses on the development of miniaturizable ion-selective arrays based on highly stable polymer membranes for biomedical applications, demonstrating potential advancements in biomedical sensor technology.

Dietary strategies by foods with antioxidant effect on nutritional management of dyslipidemias: a systematic review – This systematic review, published in Antioxidants in 2021, explores dietary strategies involving foods with antioxidant effects for the nutritional management of dyslipidemias, offering insights into potential dietary interventions for managing lipid disorders.

Author Metrics ๐Ÿ“Š :ย 

Dr. Lugo’s publications have received attention and citations, indicating their impact and contribution to the field of biomedical research.

๐Ÿ“… Research Timeline:

Throughout his career, Dr. Lugo has held positions at various institutions, including the International Iberian Nanotechnology Laboratory, Hospital Juarez de Mexico, the University of Oxford, and the Universidad Autonoma de Yucatan. He has contributed to projects focusing on cancer research, chronic kidney disease, and other areas of biomedical research.

Dr Roberto Lugo | Clinical Research Award | Best Researcher Award |

You May Also Like